Published in Biochim Biophys Acta on October 12, 1994
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine (2006) 4.08
Protein adsorption on surfaces with grafted polymers: a theoretical approach. Biophys J (1997) 2.26
Sheddable coatings for long-circulating nanoparticles. Pharm Res (2007) 2.15
Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J Pharm Sci (2011) 1.24
The effects of ethylene oxide containing lipopolymers and tri-block copolymers on lipid bilayers of dipalmitoylphosphatidylcholine. Biophys J (1997) 1.02
Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies. Antimicrob Agents Chemother (1997) 1.00
Stealth properties to improve therapeutic efficacy of drug nanocarriers. J Drug Deliv (2013) 0.99
Effect of cholesterol nanodomains on the targeting of lipid-based gene delivery in cultured cells. Mol Pharm (2010) 0.95
Size and structure of spontaneously forming liposomes in lipid/PEG-lipid mixtures. Biophys J (2002) 0.90
Surface engineering of liposomes for stealth behavior. Pharmaceutics (2013) 0.90
The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro. Ther Deliv (2011) 0.89
Designer lipids for drug delivery: from heads to tails. J Control Release (2014) 0.88
Effect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)s. Pharm Res (2007) 0.83
Ligands located within a cholesterol domain enhance gene delivery to the target tissue. J Control Release (2012) 0.83
Encapsulation and release of Amphotericin B from an ABC triblock fluorous copolymer. Pharm Res (2011) 0.81
Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries. Int J Nanomedicine (2014) 0.78
Co-encapsulating the fusogenic peptide INF7 and molecular imaging probes in liposomes increases intracellular signal and probe retention. PLoS One (2015) 0.76
Effect of surface coating of KYb2F7:Tm(3+) on optical properties and biomedical applications. Nanotechnology (2016) 0.75
Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody. Int J Nanomedicine (2016) 0.75
Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: the RESTORE-2 trial. Eur J Surg Oncol (2012) 2.08
Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta (1994) 1.82
Vascular permeability in a human tumour xenograft: molecular charge dependence. Br J Cancer (2000) 1.60
Temperature-dependent aggregation of pH-sensitive phosphatidyl ethanolamine-oleic acid-cholesterol liposomes as measured by fluorescent spectroscopy. Anal Biochem (1992) 0.93
Toxicity and immunogenicity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes. Infect Immun (1992) 0.91
New synthetic amphiphilic polymers for steric protection of liposomes in vivo. J Pharm Sci (1995) 0.87
Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification. Biomaterials (2001) 0.86
Deactivation of mycotoxins. I. An in vitro study of zearalenone adsorption on new polymeric adsorbents. J Environ Sci Health B (1999) 0.78
High throughput screening assay for UDP-glucuronosyltransferase 1A1 glucuronidation profiling. Assay Drug Dev Technol (2007) 0.77
Stabilization of human prostate acid phosphatase by cross-linking with diimidoesters. Acta Biochim Pol (1987) 0.77
On the possibility of the unification of drug targeting systems. Studies with liposome transport to the mixtures of target antigens. Biochem Pharmacol (1987) 0.77
Interaction between oleic acid-containing pH-sensitive and plain liposomes. Fluorescent spectroscopy studies. FEBS Lett (1992) 0.77
Amphiphilic poly-N-vinylpyrrolidone nanoparticles as carriers for non-steroidal anti-inflammatory drugs: characterization and in vitro controlled release of indomethacin. Int J Mol Med (2010) 0.76
Monoclonal antibody to human endothelial cell surface internalization and liposome delivery in cell culture. FEBS Lett (1988) 0.76
Artificial and natural thermostabilization of subunit enzymes. Do they have similar mechanism? Int J Biochem (1985) 0.75
Effect of novel water-soluble polymeric forms of sorbic acid against Fusarium oxysporum f.sp. radicis-cucumerinum. Food Addit Contam (2000) 0.75
Orthoclone OKT3: an overview of the monoclonal antibody and the nursing considerations it presents. Crit Care Nurse (1991) 0.75
Visualizing renal anatomy and function with 1-10,000-nm radiocontrast agents. Acad Radiol (1998) 0.75
The Cambrian period of nonviral gene delivery. Nat Biotechnol (1998) 0.75
Disulfide cross-linked Fab-aggregates: preparation and biodistribution. J Drug Target (1998) 0.75
Interaction of polymer aggregates based on stearoyl-poly-N-vinylpyrrolidone with blood components. Biochemistry (Mosc) (2004) 0.75
Stabilization of subunit enzymes by intramolecular crosslinking with bifunctional reagents. Ann N Y Acad Sci (1984) 0.75
Transplantation's newest weapon FK 506. Am J Nurs (1991) 0.75
Using clinical innovations for research-based practice. AACN Clin Issues Crit Care Nurs (1994) 0.75
In vivo targeting of acute myocardial infarction with negative-charge, polymer-modified antimyosin antibody: use of different cross-linkers. J Nucl Cardiol (1998) 0.75
Transfection of Kasumi-1 cells with a new type of polymer carriers loaded with miR-155 and antago-miR-155. Cancer Gene Ther (2013) 0.75
Self-assembling systems based on amphiphilic poly-N-vinylpyrrolidone and their interaction with model proteins. Biochemistry (Mosc) (2003) 0.75
Stabilization of human prostatic acid phosphatase by coupling with chondroitin sulfate. Biotechnol Appl Biochem (1991) 0.75